Zobrazeno 1 - 10
of 8 220
pro vyhledávání: '"Kallenbach"'
Publikováno v:
International Journal of COPD, Vol Volume 15, Pp 775-786 (2020)
Bo Ding,1 Lee Kallenbach,2 Lukas Slipski,2 Alan Wilk,2 Dan O’Brien,2 Deniz Guranlioglu3 1AstraZeneca, Gothenburg, Sweden; 2Practice Fusion, San Francisco, CA, USA; 3AstraZeneca, Cambridge, UKCorrespondence: Bo DingAstraZeneca, Pepparedsleden 1, Got
Externí odkaz:
https://doaj.org/article/22b5c2a9f0ec423ea62279f67c65693f
Publikováno v:
International Journal of COPD, Vol Volume 14, Pp 2625-2637 (2019)
Frank Trudo,1 Lee Kallenbach,2 Joseph Vasey,2 Yen Chung,1 Alan Wilk,2 Lukas Slipski,2 Dan O’Brien,2 Charlie Strange3 1Respiratory and Inflammation Therapeutic Area, AstraZeneca, Wilmington, DE, USA; 2Life Sciences, Practice Fusion, San Francisco, C
Externí odkaz:
https://doaj.org/article/7f226e8d7cff4dffa11fbe69339dd9e4
In mixed-focus collaboration, group members create content both individually as a kind of groundwork for discussion and further processing as well as directly together in group work sessions. In case of individual creation, separate documents and con
Externí odkaz:
https://tud.qucosa.de/id/qucosa%3A75507
https://tud.qucosa.de/api/qucosa%3A75507/attachment/ATT-0/
https://tud.qucosa.de/api/qucosa%3A75507/attachment/ATT-0/
Publikováno v:
Clinical Epidemiology, Vol Volume 10, Pp 1667-1677 (2018)
Katherine E Mues,1 Alina N Bogdanov,2 Keri L Monda,1 Larisa Yedigarova,3 Alexander Liede,1 Lee Kallenbach2 1Center for Observational Research, Amgen Inc., Thousand Oaks, CA, USA; 2Practice Fusion, San Francisco, CA, USA; 3US Medical Affairs, Amgen In
Externí odkaz:
https://doaj.org/article/ccdce9bc35de46ada67b3066997f862c